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Aging reduces the accuracy of self-reported
walking limitation in patients with vascular-type
claudication
Pierre Abraham, MD, PhD,a,b Nafi Ouedraogo, MD,a,b Garry A. Tew, PhD,c Bruno Vielle, MD,d
Georges Leftheriotis, MD, PhD,a,b and Guillaume Mahe, MD, PhD,a,b Angers, France; and Sheffield,
United Kingdom
Background: The published correlations between treadmill performance and the Walking Impairment Questionnaire
(WIQ) score are generally fair. We hypothesized that the slope of the relationship of maximal treadmill walking time to
WIQ would be lower in older than in younger patients, resulting in (1) a fair correlation in the population considered as
a whole and (2) different cutoff points of the WIQ score to predict the ability to complete 5 minutes of treadmill walking
in different age groups.
Methods: A 9-month prospective study was performed among patients referred for vascular-type claudication. Patients
were divided into three age groups by years: <60 (group 1, n  91), 60 to 70 (group 2, n  80), and >70 (group 3,
n 77). Patients self-completed the WIQ, which was corrected with a nurse, if necessary, and then completed a treadmill
test. We calculated the correlation coefficient and slope of the relationship between the WIQ and maximal treadmill
walking time. We used receiver operating characteristics curve analysis to estimate the accuracy of the WIQ score to
determine the ability of the patients to complete 5 minutes of treadmill walking.
Results: Differences in slopes were significant between groups 1 vs 2 (P  .02), 2 vs 3 (P < .002), and 1 vs 3 (P < .001).
The R2 for the regression lines also tended to decrease but was only significant between two extremes (1 vs 2, P  .11;
2 vs 3, P  .07; 1 vs 3, P < .001). In patients aged <60 years (group 1), a WIQ score of 47 predicted the ability to
complete a 5-minute test on treadmill with 86.8% accuracy (area under the receiver operating characteristics curve, 0.906;
P < .001). The accuracy in predicting treadmill results from the WIQ score was fair in group 2 and nonsignificant in
group 3.
Conclusions: Prediction of treadmill walking capacity from the WIQ score should account for age. The TransAtlantic
Inter-Society Consensus suggests that self-reported limitation has an equal weight as measured walking distance in the
treatment choices and follow-up of patients with peripheral arterial disease. The WIQ should probably be used with
caution in clinical routine, and constant-load treadmill testing is probably not the ideal candidate in elderly patients. New
or adapted tools are likely needed in such patients but remain to be studied. (J Vasc Surg 2012;56:1025-31.)
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cIn patients with claudication, such as can result from
peripheral artery disease (PAD), walking-induced leg pain
forces the patient to stop after a specific distance or time.
Various questionnaires have been proposed to estimate
reduced function, but their correlation with objective mea-
sures is fair, at best. Among available questionnaires is the
Walking Impairment Questionnaire (WIQ), a 14-item
questionnaire that includes the subscales of distance, speed,
and stair climbing, which was originally proposed to stan-
dardize patients’ answers.1,2 The WIQ seems to be one of
From the LUNAM Université, CNRS, UMR6214, and INSERM, U1083,
Angersa; the Laboratory for Vascular Investigations, Université d’Angers,
CHU, Angersb; the Centre for Sport and Exercise Science, Sheffield
Hallam University, Sheffieldc; and the Department of Biostatistics, Uni-
versity Hospital, Angers.d
Author conflict of interest: none.
Reprint requests: Prof Pierre Abraham, Laboratory for Vascular Investiga-
tions, University Hospital, 4 Rue Larrey, CHU d’angers 49933 Angers
Cedex 09, France (e-mail: piabraham@chu-angers.fr).
The editors and reviewers of this article have no relevant financial relation-
ships to disclose per the JVS policy that requires reviewers to decline
review of any manuscript for which they may have a conflict of interest.
0741-5214/$36.00p
Copyright © 2012 by the Society for Vascular Surgery.
http://dx.doi.org/10.1016/j.jvs.2012.03.258he most widely used questionnaires in patients with clau-
ication and has been translated in several languages.3-8
Many studies have assessed the association between
easured walking capacity and the WIQ score, but the
ffect of age over this association has not been reported.
ur hypothesis is that (1) the slope of the relationship of
aximum walking time (MWT) to the WIQ score is lower
n older than in younger patients and that (2) the relation-
hip of MWT to WIQ is relatively high in each age group
Pearson r  0.60) but relatively low (r  0.60) in the
opulation considered as a whole due to between-group
ifferences in regression slopes. Further, the optimal cutoff
oint of theWIQ score that predicts the ability to complete
minutes of standardized treadmill walking has not been
efined in different age groups.
Community walking speed decreases with age in the
eneral population9 as well as in PAD patients,10 whereas
he speed for treadmill testing is the same for all patients.
e therefore hypothesized, for the same reason as above,
hat the accuracy of the WIQ to predict the patient’s ability
o complete 5 minutes of treadmill walking would be
omparable between different age groups due to the ex-
ected high subgroup correlation coefficients and that the
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increasing age as a consequence of expected lower slopes.
Our primary aim was to assess if the relationship of
MWT toWIQ score changes between different age groups.
Our secondary aim was to estimate the optimal WIQ cutoff
points that predict the ability to complete 5 minutes of
treadmill walking in different age groups.
METHODS
This study was approved by the local Ethics Commit-
tee, conformed to the Declaration of Helsinki, and was an
ancillary study of theWalking ImpairmentQuestionnaire in
PAD (WELCH) study (NCT01114178 on the http://
clinicaltrial.gov Web site).
Study population. During the study period, starting
in January 2011, all new patients referred to our laboratory
for vascular-type claudication (claudication of suspected
vascular origin) and who fulfilled the inclusion and exclu-
sion criteria were invited to participate in this prospective
study. Claudication is of vascular type and thus assumed to
result from PAD if limb pain or discomfort is absent at rest,
occurs during walking, forces the patient to slow down or
stop walking, and disappears10minutes of recovery from
walking.11 Inclusion and exclusion criteria were ability to
walk on a treadmill, French native-language speaker, age
18 years, stable vascular-type claudication for 3
months, absence of known cognitive or psychiatric disor-
ders, and ability to read without the assistance of another
person. Written informed consent was obtained for all
patients.
Only the first visit was included for patients who were
referred twice during the study period. Patient characteris-
tics, medical history, and treatments were retrieved from
medical files, and missing data were completed by patient
interview, if necessary.
Completion and correction of the WIQ. The WIQ
was self-completed by each patient and checked for com-
pletion by a technician or a nurse before the treadmill test.
Reading glasses were provided, if necessary. Missing (no
answer to an item), duplicate (2 answers to the same
item), or paradoxic answers (eg, higher difficulty for an
easier task) were discussed with the patient by a trained
nurse and corrected, as previously reported.12
Scoring of the WIQ questionnaires. Scoring of the
WIQ was performed as previously reported6,12-14 and re-
sults in four scores per patient: one score for each subscale
and the overall score, which is the mean of the three
subscale scores. All scores range from 0 (impossible to
complete the task) to 100 (no difficulty in walking 500
meters, running 1 block, and climbing 3 flights of stairs).
Walking speed over 10meters. While going from the
waiting room to the test room, the time taken to walk 10
meters was measured for each patient with a stopwatch to
calculate usual walking speed. Attention was paid not to
walk in front of the patient to avoid influencing the pa-
tient’s speed.
Walking capacity on treadmill. After resting 15
minutes, patients completed a treadmill test to maximum plaudication pain or exhaustion, or both. The first 15
inutes of walking were performed at 3.2 km/h and a 10%
lope. After 15 minutes, the slope and speed were progres-
ively increased in 1-minute steps, as previously reported.6
his combination of constant load and incremental proce-
ures resulted in all patients being limited on the treadmill.
he MWT was recorded for all tests. Physicians supervising
he treadmill test were blinded to the result of the WIQ.
Sample size calculation and statistical analysis. The
opulation was divided into three age groups by years:60
group 1), 60 to 70 (group 2), and 70 (group 3). A
inimum of 61 individuals were required in each group to
stimate the coefficient of correlation with a two-sided
ypothesis,   0.05 and power  90%. The study was
tarted on January 2011, was expected to last 1 year, and
as stopped for completion after 3 trimesters of inclusions.
Results are presented as mean  standard deviation or
edian (25th-75th percentiles) for continuous data ac-
ording to distribution and as number (percentage) for
ategoric data. Between-group differences were assessed
sing analysis of variance and Bonferroni post hoc compar-
sons for continuous variables and 2 adjusted for multiple
omparisons for categoric variables. The r2 coefficients for
he linear regression analyses of MWT to WIQ scores were
alculated for each age group and for the whole population
hile constraining the origin of the regression to 0. Finally,
e used a receiver operating characteristics (ROC) curve
nalysis to estimate the accuracy ofWIQ score to determine
he ability of the patients to complete 5 minutes of tread-
ill walking. Statistical significance of the areas under the
urves was tested against the area of the diagonal, which is
.5 (the value that would result from a random choice).
ssuming an equal cost of false-positive and false-negative
ests, the shorter distance of the ROC curve to the 100%
ensitivity and 100% specificity angle was used to determine
he optimal cutoff point of this determination. Accuracies,
ensitivity, and specificity are reported with 95% confidence
ntervals. Analyses were performed using SPSS 15.0 soft-
are (SPSS Inc, Chicago, Ill), with statistical significance
et at P  .05.
ESULTS
Of the 278 patients admitted during the study period,
50 different patients were referred consecutively to the
epartment for vascular-type claudication and were invited
o participate; of these, one patient refused to participate
nd one patient, who was included by error, was ineligible
nd was excluded.
Population studied. Characteristics, history, and treat-
ents of the 248 patients (196 men, 52 women) are pre-
ented in Table I. The patients were 169  8 cm tall,
eighed 77.1 15.9 kg, and were aged 63.5 12.7 years.
AD was diagnosed in 213 (85.9%), and 60 (24.2%) were
iabetic (14 type 1 and 46 type 2).
Completion and scoring of the questionnaires.
fter self-completion of the WIQ, we found 573 errors
ithin the 3472 items (16.5%) that had to be completed. This
roportion increased with groups, as reported in Table II,
o
g
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Volume 56, Number 4 Abraham et al 1027with 115 errors (7.5%) in group 1, 190 (10.9%) in group 2,
and 268 (14.8%) in group3.Overall, 106WIQs (42.7%)were
corrected for one or more errors. There was a trend for a
decrease in all WIQ scores with an increase in age, with scores
Table I. Characteristics, history, and treatments of the pat
Variablea
Grou
(60
(n 
Characteristics
Age, years 52 (47
Height, cm 171 
Weight, kg 76.1 
Body mass index, kg/m2 20.0 
Sex
Males 71
Females 20
Active smokers 42 (46
Arterial pressure, mm Hg
Systolic 130 (12
Diastolic 75 (70
Heart rate at rest, beats/min 84 
Resting pulse oximetry, % 97.8 
Lowest ankle-brachial index 0.93 (0.7
History
Diabetes 14 (15
Evidence of PAD 73 (80
Cardiac disease 17 (19
Lumbar or leg osteoarticular surgery 15 (16
Treatment
Antiplatelet or anticoagulant 59 (65
-blocker 21 (23
Antidiabetic or insulin 12 (13
Cholesterol-lowering drugs 44 (48
Neuropsychiatric and analgesic
drugs 23 (25
Bronchodilators 12 (13
Antihypertensive drugs 45 (49
Other drugs 35 (38
PAD, Peripheral arterial disease.
aContinuous data are shown as mean  standard deviation or median (25th
bP  .05 between groups 1 and 2.
cP  .05 between groups 2 and 3.
dP  .05 between groups 1 and 3.
Table II. Data for self-reports, 10-meter walking speed, a
Variablea
Group 1
(60 years)
WIQ score
Overall 52 (35-76)
Distance 60 (30-100)
Speed 46 (25-72)
Stair climbing 54 (31-88)
WIQs with errors, No. 31 (34)
Speed over 10 meters, km/h 4.2 (3.8-4.5)
MWT on treadmill, sec 548 (165-1111
MWT, Maximal walking time; WIQ, Walking Impairment Questionnaire.
aContinuous data are shown as median (25th-75th percentile) and categori
bP  .05 between groups 2 and 3.
cP  .05 between groups 1 and 3.
dP  .05 between groups 1 and 2.being significantly lower in group 3 (Table II). wWalking speed over 10 meters. Usual walking speed
ver 10 meters was higher in group 1 than in the other
roups (Table II).
MWT on treadmill. The total test duration decreased
in each age group
Group 2 Group 3
(60-70 years) (70 years)
(n  80) (n  77)
65 (62-67)b 77 (74-81)c,d
169  7.5 165  8c,d
80.2  14.5 75.0  14.9
27.9  4.2b 27.3  4.3c
69 56
11 21
22 (28)b 8 (10)c
) 137 (125-149) 148 (126-160)c
75 (75-80) 77 (75-80)
75  18b 75 16c
97.7  1.7 97.7  1.4
2) 0.84 (0.65-1.00) 0.71 (0.60-0.96)c
27 (34)b 19 (25)
68 (85) 72 (94)c
22 (28) 23 (30)
15 (19) 23 (30)
65 (81)b 70 (91)c
33 (41)b 30 (39)
24 (30)b 19 (25)
56 (70)b 53 (69)c
18 (23) 33 (43)c,d
11 (14) 11 (14)
54 (68)b 70 (91)c,d
43 (54) 58 (75)c,d
percentiles) and categoric data as number (%).
eadmill tests in each group
Group 2 Group 3
(60-70 years) (70 years)
49 (30-62) 33 (17-49)b,c
57 (29-77) 32 (15-50)b,c
39 (25-54) 25 (14-33)b,c
46 (29-67) 33 (17-50)b,c
32 (40) 43 (56%)b,c
3.9 (3.6-4.2)d 3.5 (3.1-3.9)b
263 (173-877)d 175 (104-226)b,c
as number (%).ients
p 1
years)
91)
-56)
8.4
17.8
5.1
)
2-141
-80)
16
1.6
2-1.0
)
)
)
)
)
)
)
)
)
)
)
)
-75thnd tr
)
c dataith the increase of age group. Of the 248 patients, 142
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October 20121028 Abraham et alwere unable to walk for 5 minutes: 37 in group 1, 41 in
group 2, and 64 in group 3; and 185 patients (74.6%)
stopped during the constant-load phase of the walking
tests. The mean duration of the incremental phase (15
minutes of constant-load exercise) for the other 63 patients
was 4.65 minutes, with the highest MWT, at 28 minutes 6
seconds, in an athlete reporting claudication only at fast
walking or running.
Relationships between MWT and WIQ scores. The
slope of the relationship and the coefficient of determina-
tion of MWT to WIQ subscores tended to decrease with
increasing age (Table III). The relationship of the MWT to
the overall WIQ score within each age group and for the
population considered as a whole are presented in the Fig.
The slopes “A” of these relationships decreased with age.
Differences in slopes were significant between group 1 vs 2
(P .02), group 2 vs 3 (P  .002), and group 1 vs 3 (P 
.001). The R2 for the regression lines also tended to
decrease but was only significant between the two extremes
(group 1 vs 2, P .11; group 2 vs 3, P .07; group 1 vs 3,
Table III. Slope “A” and coefficients of determination
(R2) of the linear regression of maximal walking time to
Walking Impairment Questionnaire (WIQ) subscores by
patient groups
WIQ
Group 1a Group 2a Group 3a
A R2 A R2 A R2
Distance 11.0 .796 8.2 .680 5.1 .407
Speed 13.4 .817 10.8 .714 7.6 .463
Stair climbing 11.4 .765 9.0 .644 4.8 .411
aGroup 1: age60 years; group 2: age 60-70 years; group 3: age70 years.
y = 12.6x
R2 = 0.840
y = 9.8x
R2 = 0.723
y = 6.3x
R2 = 0.477
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ALL PATIENTS
AGE GROUPS
Fig. Scatterplot shows maximum walking distance to the overall
Walking Impairment Questionnaire (WIQ) score for each age
group.P  .001). oAccuracy of the WIQ to predict the ability to com-
lete 5 minutes of treadmill walking. As reported in
able IV, the accuracy of WIQ scores to predict the ability
f patients to complete 5 minutes of treadmill walking
ecreased from groups 1 to 3 and was not significantly
ifferent from the diagonal (the line that would result from
random choice) in group 3. The predictive accuracy of the
IQ was better in group 1 than in the other groups. The
ptimal cutoff points for groups 1 and 2 were close, at 47
nd 53, respectively. Using these cutoffs values, accuracy,
ensitivity, and specificity were, respectively, 86.8% 7.0%,
6.5% 11.0%, and 87.0% 9.0% for group 1 and 67.5%
0.3%, 73.2%  13.6%, and 61.5%  15.5% for group 2.
he cutoff value, accuracy, sensitivity, and specificity for
roup 3 were not calculated because the area was not
ifferent from a random choice.
ISCUSSION
The study confirms our primary hypothesis that the
lope of the relationship of treadmill MWT to WIQ scores
ecreases with increased age. Unexpectedly, the coefficient
f correlation of MWT to WIQ also decreased in groups of
igher age. Finally, the accuracy of the WIQ and the
ptimal cutoff point to predict the ability to complete a
-minute treadmill walk was lower in older patients, with
onsignificant results in the oldest group.
The number of errors observed after self-completion
f the questionnaires was highest in patients aged 70
ears. The most intuitive explanation is that undiagnosed
ognitive dysfunction, which could impair the ability to
elf-complete questionnaires, was most prevalent in the
ldest age group. The prevalence of cognitive dysfunction
as been reported as 18.3% in adults aged75 years and is
hown to increase with age.15 Higher subclinical cognitive
ysfunction has also been reported in patients with PAD
han in those without PAD.16 Another possible explanation
ould be differences in the level of education or in socio-
conomic status between groups. In 2009, the proportion
f adults who did not complete a secondary school level was
1.4% in those aged 65 years but only 15% in those aged
5 to 49 years, suggesting that the educational status of the
rench population has increased in the last few decades.17
The observed decrease in 10-meter walking speed with
ncreasing age is quite logical: age and PAD are known to
educe usual walking speed.18 It is particularly interesting
o note that the relationship of the WIQ speed subscale to
he walking speed over 10 meters was almost identical in all
roups. Because usual walking speed decreases with age, we
xpected that the slope of theMWT toWIQ speed subscale
ould be altered and would possibly influence the overall
core, but this difference was also observed with the dis-
ance and stair-climbing subscales.
The decrease with age of the slope of MWT to WIQ
oes not necessarily mean that the relationship between
hese variables should be affected. We observed a decrease
n correlation with increasing age, which, again, might be
xplained by cognitive dysfunction reducing the accuracy
f self-reported walking limitation. The decrease in the
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Volume 56, Number 4 Abraham et al 1029range of MWT observed in groups of increasing age might
mathematically have reduced the correlation to WIQ. An-
other explanation could be that the range of distances
proposed to patients in the WIQ does not fit the usual
community walking and physical activity of most patients
aged 70 years. Most of these patients walk 4000 steps
daily.19,20 Then, the proposed distances are possibly not
relevant to the elderly. Consistently, many older patients
report that they do not use stairs or run and say that they are
unable to complete some items. Very few studies have
focused on the relationship of self-reported limitation to
measured MWT in elderly PAD patients.
A point of interest is that the decrease in the correlation
coefficient was also observed if the origin of the regression
line was not forced to 0 (data not shown), but the choice
was to try to compare all regressions on the slope value
alone. Nevertheless, it is quite logical that a patient scoring
0 (impossible to complete) on all WIQ items would be
completely unable to walk (maximal treadmill walking dis-
tance 0).Whatever the explanations might be, our results
suggest that caution should be taken in the use of self-
reported walking capacity in older patients. The results of
the present study are difficult to directly compare with
previous reports; indeed, methods of measuring walking
capacity differ from one study to another.
When the mean age of the studied population and the
coefficient of correlation of estimated to measured MWD
found in previous studies4,6-8,12,21,22 are plotted together,
there is a positive relationship of age and coefficient of
correlations between self-reported andmeasuredMWD. In
fact, this positive relationship seems to result from one
small study in diabetic and PAD patients who were a mean
age of 73.4 years, where the WIQ was compared with the
Table IV. Area under the receiver operating characteristic
5 minutes of treadmill walking
WIQ scores by group AUROC curve
Group 1 (60 years)
Overall .906
Speed .877
Distance .887
Stair climbing .787
Group 2 (60-70 years)
Overall .751
Speed .756
Distance .739
Stair climbing .655
Group 3 (70 years)
Overall .645
Speed .591
Distance .642
Stair climbing .630
Whole population
Overall .823
Speed .812
Distance .805
Stair climbing .727
CI, Confidence interval; SD, standard deviation; WIQ, Walking Impairmen6-minute walk test and showed a high value compared with oost reported experiments (r  0.88).7 Apart from this
pecific study, the correlation coefficient of MWT to the
verall WIQ score observed in the present study (r 0.66)
s in the range of those previously reported. We think that
his fair relationship at least partly results from the differ-
nce of the slope of the relationship between treadmill-
easured walking capacity and the WIQ score found in
ifferent age groups and the very low correlation observed
n elderly patients.
Is the WIQ only useful if it correlates with the MWT?
ossibly not, but the ability to complete 5 minutes of
readmill walking at 3.2 km/h and a 10% to 12% slope has
een proposed as a standard to classify patients with clau-
ication.23 Treadmills are not always readily accessible to
he clinician. As a result, self-reports are largely used in
linical routine, and recent recommendations from the
ransAtlantic Inter-Society Consensus (TASC) have inte-
rated the overall treatment strategy of PAD proposed by
iatt24 that gives an equal weight of a “reduced function
y questionnaire” to a “reduced treadmill performance.”
he low correlation between questionnaire and treadmill
esults is puzzling in this perspective.
Last, although the most likely explanation of the results
bserved in elderly patients is the relative inability of these
atients to self-complete questionnaires, perhaps treadmill
WT is less useful in elderly patients compared with the
IQ because elderly patients that usually walk slower (as
hown by the 10-m walking speed test) may not adapt to
ests at a constant of 3.2 km/h as well as young patients.
aybe other specific instruments and end points (eg,
-minute walk distance, incremental shuttle walk test,
lobal positioning system recorders) should be preferred in
linical studies that include elderly patients. This is an issue
ROC) curve for the prediction of the ability to complete
SD 95% CI P
.031 .846–.967 .001
.038 .802–.953 .001
.036 .817–.958 .001
.048 .694–.881 .001
.053 .647–.856 .001
.053 .652–.860 .001
.055 .631–.847 .001
.061 .535–.775 .017
.079 .491–.799 .101
.079 .435–.746 .305
.073 .499–.785 .109
.078 .477–.784 .140
.026 .771–.875 .001
.027 .759–.866 .001
.028 .751–.859 .001
.032 .665–.790 .001
stionnaire.(AUf interest for future studies.
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October 20121030 Abraham et alThere are many limitations in the present work. First,
we did not estimate sociocultural status or cognitive func-
tion, which prevents us from assessing the role of these
factors in our findings. The association between impaired
physical capacity and cognitive dysfunction has been largely
assessed,25-27 but the fact that cognitive dysfunction might
be a cause of impaired ability to self-report walking capacity
in PAD patients has never been investigated. Future stud-
ies, including evaluation of a socioeconomic status and
cognitive function, are needed to determine if these factors
contribute to the reduced accuracy of self-reported walking
capacity with increasing age in patients with claudication.
The second limitation relates to the fact that we studied
patients with vascular-type claudication on the basis of
symptoms reported by history. Patients with claudication
even fulfilling vascular-type criteria may have a normal
resting ankle-brachial index. The resting ankle-brachial in-
dex provides evidence, not proof, that claudication is of
vascular origin, at least if the lesion is on the aortoiliofemo-
ral axis or leg arteries. Because of the specific interest of our
laboratory on buttock claudication, we receive a large num-
ber of patients with isolated proximal ischemia such as can
result from isolated lesions to the internal iliac artery.
Evidence of PAD in these patients hardly relies on ankle-
brachial index.
Third, the large proportion ofmen in the studied group
is unusual but consistent with our previous reports.6,12,28
Finally, although our treadmill procedure is useful for
attaining a limitation in all studied patients, it may limit the
generalizability of the results. Future studies should be
done to confirm our results with other populations and
treadmill procedures.
CONCLUSIONS
When treadmill-walking capacity is used as a reference,
the slope of the relationship of the treadmill MWT to the
WIQ score was lower in older than in younger patients.
Further, self-reported estimation of walking capacity ap-
pears inadequate in patients aged70 years but fairly good
in patients aged 60 years. The accuracy in predicting
treadmill results from the WIQ score is very low in patients
aged 70 years, such that estimation of treadmill-walking
limitation with questionnaires should probably be used
with caution. Constant-load treadmill testing is probably
not the ideal candidate for the estimation of walking capac-
ity in elderly patients. Future studies are to be performed to
define the adequate measurement tool to be used in such
patients.
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